Homecomputing

computing

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

computing

Encryption could fend off future quantum threats

Jim Cornall - April 17, 2025

computing

Open-source quantum computer OS launched

Jim Cornall - March 24, 2025

computing

Croptimus wins innovation award

Jim Cornall - February 25, 2025

computing

ZuriQ raises $4.2m to break quantum computing scaling barrier

Jim Cornall - January 24, 2025

AI

Pasqal and EDF address electric vehicle charging with quantum computing

Jim Cornall - January 23, 2025

computing

Wultra secures €3m to protect financial institutions from quantum threats

Jim Cornall - January 20, 2025

computing

Are we heading towards a data doomsday?

Jim Cornall - November 18, 2024

computing

One step closer to quantum technologies: Fundamental quantum model recreated from nanographenes

Jim Cornall - November 5, 2024

12 3 4 Page 1 of 4

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0